Study of molecular basis of thyroid dysgenesis
Autor: | Nina A. Makretskaya, Olga B. Bezlepkina, Anna A. Kolodkina, Alexey V. Kiyaev, Evgeny V. Vasilyev, Vasily M. Petrov, Olga A. Chikulaeva, Oleg A. Malievsky, Ivan I. Dedov, Anatoliy N. Tyulpakov |
---|---|
Jazyk: | ruština |
Rok vydání: | 2018 |
Předmět: | |
Zdroj: | Клиническая и экспериментальная тиреоидология, Vol 14, Iss 2, Pp 64-71 (2018) |
Druh dokumentu: | article |
ISSN: | 1995-5472 2310-3787 |
DOI: | 10.14341/ket9556 |
Popis: | Congenital hypothyroidism is a heterogeneous group of diseases, which is manifested by loss of function of the thyroid gland that affects infants from birth. 8085% of cases are due to different types of thyroid dysgenesis. 5 genes have been described that are involved in the pathogenesis of thyroid dysgenesis: TSHR, PAX8, FOXE1, NKX2-1, NKX2-5. Aims. To evaluate the prevalence of mutations in the genes TSHR, PAX8, FOXE1, NKX2-1, NKX2-5 among patients with severe congenital hypothyroidism. Materials and methods. 161 patients (64 boys, 97 girls) with congenital hypothyroidism (TSH levels at neonatal screening or retesting greater than 90 mU/l) were included in the study. 138 subjects had different variants of thyroid dysgenesis, and 23 patients had normal volume of the gland. A next generation sequencing was used for molecular-genetic analysis. Sequencing was performed using PGM semiconductor sequencer (Ion Torrent, Life Technologies, USA) and a panel Hypothyroidism (Custom DNA Panel). Assessment of the pathogenicity of sequence variants were carried out according to the latest international guidelines (ACMG, 2015). Results. 13 patients had variants in thyroid dysgenesis genes (8,1%, 13/161): TSHR, n = 6; NKX2-1, n = 3; NKX2-5, n = 1; PAX8, n = 3; FOXE1, n = 0. Conclusions. Mutations in thyroid dysgenesis genes are a rare pathology. The majority of variants among our patients were identified in TSHR. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |